ZZL-7
Product Specifications
UNSPSC Description
ZZL-7 is a fast-onset antidepressant agent. ZZL-7 works by disrupting the interaction between the serotonin transporter (SERT) and neuronal nitric oxide synthase (nNOS) in the dorsal raphe nucleus (DRN). ZZL-7 can cross the blood-brain barrier readily. ZZL-7 can be used for the research of major depressive disorder (MDD)[1].
Target Antigen
Serotonin Transporter
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/zzl-7.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC(C)[C@@H](C(OC)=O)NC([C@H](C)NC(C)=O)=O
Molecular Weight
244.29
References & Citations
[1]Nan Sun, et al. Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN. Science. 2022 Oct 28;378(6618):390-398.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148417/ZZL-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148417/ZZL-7-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
99141-91-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6457262-01 0.2 mL
MINOS1 (MICOS Complex Subunit MIC10, Mitochondrial inner Membrane organizing system Protein 1, MINOS1, C1orf151, MIC10) (AP)
Ask
View Details 
MBS6457262-02 5x 0.2 mL
MINOS1 (MICOS Complex Subunit MIC10, Mitochondrial inner Membrane organizing system Protein 1, MINOS1, C1orf151, MIC10) (AP)
Ask
View Details 